- Home
- MLYS vs ACIC Comparison
MLYS vs ACIC Comparison
Compare MLYS & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MLYS | ACIC |
|---|---|---|
| Founded | 2019 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 625.2M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MLYS | ACIC |
|---|---|---|
| Price | $37.20 | $12.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $47.33 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 116.0K |
| Earning Date | 02-11-2026 | 11-05-2025 |
| Dividend Yield | N/A | ★ 5.98% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.71 |
| Revenue | N/A | ★ $328,331,000.00 |
| Revenue This Year | N/A | $5.03 |
| Revenue Next Year | N/A | $2.40 |
| P/E Ratio | ★ N/A | $7.24 |
| Revenue Growth | N/A | ★ 22.22 |
| 52 Week Low | $8.24 | $9.97 |
| 52 Week High | $47.65 | $13.78 |
Technical Indicators
Market Signals| Indicator | MLYS | ACIC |
|---|---|---|
| Relative Strength Index (RSI) | 43.16 | 52.87 |
| Support Level | $36.50 | $12.51 |
| Resistance Level | $38.23 | $13.06 |
| Average True Range (ATR) | 1.68 | 0.27 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 41.96 | 51.62 |
Price Performance
Historical ComparisonAbout MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.